2-Deoxyglucose Induces Cell Cycle Arrest and Apoptosisin Colorectal Cancer Cells Independent of Its Glycolysis Inhibition

REFERENCES

• Warburg O, Posener K, and Negelein E: Uber den Stoffwechsel der Carcinomzelle. Biochem Z 152, 309–344, 1924.
   Google Scholar
• Vander Heiden MG, Cantley LC, and Thompson CB: Understanding the Warburg effect: the metabolic requirements of cell proliferation, Science 234, 1029–1033, 2009.
   Web of Science ®Google Scholar
• Sakamoto T, Niiya D, and Seiki M: Targeting the Warburg effect that arises in tumor cells expressing membrane type-1 matrix metalloproteinase. J Biol Chem 286, 14691–14704, 2011.
   PubMed Web of Science ®Google Scholar
• Jung DW, Kim WH, Park SH, Lee J, Kim J, et al.: A unique small molecule inhibitor of enolase clarifies its role in fundamental biological processes. ACS Chem Biol 8, 1271–1282, 2013.
   PubMed Web of Science ®Google Scholar
• Li S, Li Y, Hu R, Li W, Qiu H, et al.: The mTOR inhibitor AZD8055 inhibits proliferation and glycolysis in cervical cancer cells. Oncol Lett 5, 717–721, 2013.
   PubMed Web of Science ®Google Scholar
• Datta S, Li J, Mahdi F, Jekabsons MB, Nagle DG, et al.: Glycolysis inhibitor screening identifies the bis-geranylacylphloroglucinol protonophore moronone from Moronobea coccinea. J Nat Prod 75, 2216–2222, 2012.
   PubMed Web of Science ®Google Scholar
• Vijayaraghavan R, Kumar D, Dube SN, Singh R, Pandey KS, et al.: Acute toxicity and cardio-respiratory effects of 2-deoxy-D-glucose: a promising radio sensitizer. Biomed Environ Sci 19, 96–103, 2006.
   PubMed Web of Science ®Google Scholar
• Raez LE, Papadopoulos K, Ricart AD, Chiorean EG, Dipaola RS, et al.: A phase I dose-escalation trial of 2-deoxy-D-glucose alone or combined with docetaxel in patients with advanced solid tumors. Cancer Chemother Pharmacol 71, 523–530, 2013.
   PubMed Web of Science ®Google Scholar
• Brown J: Effects of 2-deoxyglucose on carbohydrate metablism: review of the literature and studies in the rat. Metabolism 11, 1098–1112, 1962.
   PubMed Web of Science ®Google Scholar
• Karczmar GS, Arbeit JM, Toy BJ, Speder A, and Weiner MW: Selective depletion of tumor ATP by 2-deoxyglucose and insulin, detected by 31P magnetic resonance spectroscopy, Cancer Res 52, 71–76, 1992.
   PubMed Web of Science ®Google Scholar
• Stein M, Lin H, Jeyamohan C, Dvorzhinski D, Gounder M, et al.: Targeting tumor metabolism with 2-deoxyglucose in patients with castrate-resistant prostate cancer and advanced malignancies. Prostate 70, 1388–1394, 2010.
   PubMed Web of Science ®Google Scholar
• Ralser M, Wamelink MM, Struys EA, Joppich C, Krobitsch S, et al.: A catabolic block does not sufficiently explain how 2-deoxy-D-glucose inhibits cell growth. Proc Natl Acad Sci USA 105, 17807–17911, 2008.
   PubMed Web of Science ®Google Scholar
• Kurtoglu M, Maher JC, and Lampidis TJ: Differential toxic mechanisms of 2-deoxy-D-glucose versus 2-fluorodeoxy-D-glucose in hypoxic and normoxic tumor cells. Antioxid Redox Signal 9, 1383–1390, 2007.
   PubMed Web of Science ®Google Scholar
• Aghaee F, Pirayesh Islamian J, and Baradaran B: Enhanced radiosensitivity and chemosensitivity of breast cancer cells by 2-deoxy-d-glucose in combination therapy. J Breast Cancer 15, 141–147, 2012.
   PubMed Web of Science ®Google Scholar
• Cheng G, Zielonka J, Dranka BP, McAllister D, Mackinnon AC Jr, et al.: Mitochondria-targeted drugs synergize with 2-deoxyglucose to trigger breast cancer cell death. Cancer Res 72, 2634–2644, 2012.
   PubMed Web of Science ®Google Scholar
• Zhu Z, Jiang W, McGinley JN, and Thompson HJ: 2-Deoxyglucose as an energy restriction mimetic agent: effects on mammary carcinogenesis and on mammary tumor cell growth in vitro. Cancer Res, 65, 7023-7030, 2005.
   Web of Science ®Google Scholar
• Tsunekawa-Imai N, Miwa H, Shikami M, Suganuma K, Nitta M, et al.: Growth of xenotransplanted leukemia cells is influenced by diet nutrients and is attenuated with 2-deoxyglucose. Leukemia Res 37, 1132-1136, 2013.
   PubMed Web of Science ®Google Scholar
• Tummala H, Jung C, Tiwari A, Higgins CM, Hayward LJ, et al.: Inhibition of chaperone activity is a shared property of several Cu,Zn-superoxide dismutase mutants that cause amyotrophic lateral sclerosis. J Biol Chem 280, 17725–17231, 2005.
   PubMed Web of Science ®Google Scholar
• Tummala H, Li X, and Homayouni R: Interaction of a novel mitochondrial protein, 4-nitrophenylphosphatase domain and non-neuronal SNAP25-like protein homolog 1 (NIPSNAP1), with the amyloid precursor protein family. Eur J Neurosci 31(11), 1926–1934, 2010.
   PubMed Web of Science ®Google Scholar
• Bandugula VR and N RP: 2-Deoxy-D-glucose and ferulic acid modulates radiation response signaling in non-small cell lung cancer cells. Tumour Biol 34(1), 251–259, 2013.
   PubMed Web of Science ®Google Scholar
• Vermeulen K, Van Bockstaele DR, and Berneman ZN: The cell cycle: a review of regulation, deregulation and therapeutic targets in cancer. Cell Prolif 36, 131–149, 2003.
   PubMed Web of Science ®Google Scholar
• Gartel AL and Tyner AL: The role of the cyclin-dependent kinase inhibitor p21 in apoptosis. Mol Cancer Ther 1(8), 639–649, 2002.
   PubMed Web of Science ®Google Scholar
• Han Z, Wei W, Dunaway S, Darnowski JW, Calabresi P, et al.: Role of p21 in apoptosis and senescence of human colon cancer cells treated with camptothecin. J Biol Chem 277, 17154–17160, 2002.
   PubMed Web of Science ®Google Scholar
• Ihrlund LS, Hernlund E, Khan O, and Shoshan MC: 3-Bromopyruvate as inhibitor of tumour cell energy metabolism and chemopotentiator of platinum drugs. Mol Oncol 2, 94–101, 2008.
   PubMed Web of Science ®Google Scholar
• Duffy MJ: The war on cancer: are we winning? Tumour Biol 34, 1275–1284, 2013.
   PubMed Web of Science ®Google Scholar
• Reutter M, Emons G, and Gründker C: Starving tumors: inhibition of glycolysis reduces viability of human endometrial and ovarian cancer cells and enhances antitumor efficacy of GnRH receptor-targeted therapies. Int J Gynecol Cancer 23, 34–40, 2013.
   PubMed Web of Science ®Google Scholar
• Sottnik JL, Lori JC, Rose BJ, and Thamm DH: Glycolysis inhibition by 2-deoxy-D-glucose reverts the metastatic phenotype in vitro and in vivo. Clin Exp Metastasis 28, 865–875, 2011.
   PubMed Web of Science ®Google Scholar
• Cheong JH, Park ES, Liang J, Dennison JB, Tsavachidou D, et al.: Dual inhibition of tumor energy pathway by 2-deoxyglucose and metformin is effective against a broad spectrum of preclinical cancer models. Mol Cancer Ther 10, 2350–2362, 2011.
   PubMed Web of Science ®Google Scholar
• Zhong D, Liu X, Schafer-Hales K, Marcus AI, Khuri FR, et al.: 2-Deoxyglucose induces Akt phosphorylation via a mechanism independent of LKB1/AMP-activated protein kinase signaling activation or glycolysis inhibition. Mol Cancer Ther 7, 809–917, 2008.
   PubMed Web of Science ®Google Scholar
• Liu H, Jiang CC, Lavis CJ, Croft A, Dong L, et al.: 2-Deoxy-D-glucose enhances TRAIL-induced apoptosis in human melanoma cells through XBP-1-mediated up-regulation of TRAIL-R2. Mol Cancer 8, 122, 2009.
   Web of Science ®Google Scholar
• Malumbres M and Barbacid M: Cell cycle, CDKs and cancer: a changing paradigm, Nature Reviews Cancer 9, 153–166, 2009.
   PubMed Web of Science ®Google Scholar
• Tetsu O and McCormick F: Proliferation of cancer cells despite CDK2 inhibition, Cancer Cell 3, 233-245, 2003.
   PubMed Web of Science ®Google Scholar
• Naruse I, Hoshino H, Dobashi K, Minato K, Mori M, et al.: Over-expression of p27 Kip1 induces growth arrest and apoptosis mediated by changes of pRB expression in lung cancer cell lines. Int J Cancer 88, 377-383, 2000.
   PubMed Web of Science ®Google Scholar
• Golding JP, Wardhaugh T, Patrick L, Turner M, Phillips JB, et al.: Targeting tumour energy metabolism potentiates the cytotoxicity of 5-aminolevulinic acid photodynamic therapy, Br J Cancer 109, 976–982, 2013.
   PubMed Web of Science ®Google Scholar
• Bénéteau M, Zunino B, Jacquin MA, Meynet O, Chiche J, et al.: Combination of glycolysis inhibition with chemotherapy results in an antitumor immune response. Proc Natl Acad Sci USA 109, 20071–20076, 2012.
   PubMed Web of Science ®Google Scholar
• Papathanassiu AE, MacDonald NJ, Emlet DR, and Vu HA: Antitumor activity of efrapeptins, alone or in combination with 2-deoxyglucose, in breast cancer in vitro and in vivo. Cell Stress Chaperones 16, 181–193, 2011.
   PubMed Web of Science ®Google Scholar
• Elmore S: Apoptosis: a review of programmed cell death. Toxicol Pathol 35, 495–516, 2007.
   PubMed Web of Science ®Google Scholar
• Tsang WP, Chau SP, Kong SK, Fung KP, and Kwok TT: Reactive oxygen species mediate doxorubicin induced p53-independent apoptosis. Life Sci 73, 2047–2058, 2003.
   PubMed Web of Science ®Google Scholar